RecruitingPhase 3NCT04499755
Efficacy of Nucleo CMP Forte in Traumatic Brain Injury in Pediatrics
Efficacy of Nucleo CMP Forte in Traumatic Brain Injury in Pediatrics: A Randomized Controlled Trial
Sponsor
Sherief Abd-Elsalam
Enrollment
100 participants
Start Date
Jun 1, 2020
Study Type
INTERVENTIONAL
Conditions
Summary
Efficacy of Nucleo CMP Forte in Traumatic Brain Injury in Pediatrics
Eligibility
Max Age: 18 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying a drug called Nucleo CMP Forte for people with brain injuries. The study is currently recruiting participants at 1 location. People eligible for this study include up to age 18 Years.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGNucleo CMP Forte
Nucleo CMP Forte twice daily for 6 weeks
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04499755
Related Trials
Mobile Health Self-Management and Support System for Chronic and Complex Health Conditions
NCT025922911 location
Screening Emotions in Adolescents at the Hospital for mTBI
NCT063705206 locations
Ketamine Infusion as a Method of Cerebral Protection in Children
NCT065255841 location
Portable MRI for Pediatric Hypoxic Ischemic Brain Injury
NCT075773361 location
The Gut-Brain Axis During Neurorehabilitation; Prebiotic Treatment to Alter the Gut Microbiome and Neurologic Symptoms
NCT066075231 location